Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to "Debt Collection Practices (Regulation F); Deceptive and Unfair Collection of Medical Debt".

Bill 118 hjres 220, also known as the "Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Bureau of Consumer Financial Protection relating to 'Debt Collection Practices (Regulation F); Deceptive and Unfair Collection of Medical Debt'", is a piece of legislation that aims to overturn a rule proposed by the Bureau of Consumer Financial Protection regarding debt collection practices, specifically in relation to medical debt.

The rule in question, known as Regulation F, seeks to address deceptive and unfair collection practices related to medical debt. It aims to provide protections for consumers who may be facing aggressive or misleading tactics from debt collectors when it comes to medical bills. The rule outlines guidelines for how debt collectors should communicate with consumers, what information they must provide, and how they should handle disputes over medical debt.

However, Bill 118 hjres 220 seeks to disapprove of this rule, arguing that it may have unintended consequences for the debt collection industry and could potentially hinder their ability to effectively collect debts. Supporters of the bill believe that the rule may be overly burdensome for debt collectors and could lead to increased costs for consumers. Opponents of the bill, on the other hand, argue that the rule is necessary to protect consumers from abusive debt collection practices, particularly when it comes to medical debt which can often be overwhelming and confusing for individuals. They believe that Regulation F provides important safeguards for consumers and should not be overturned. Overall, Bill 118 hjres 220 is a contentious piece of legislation that highlights the ongoing debate over how best to regulate debt collection practices, particularly in relation to medical debt. It remains to be seen how Congress will ultimately decide on the fate of Regulation F and its implications for consumers and the debt collection industry.